HighTower Advisors’s Citius Pharmaceuticals CTXR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-8,601
| Closed | -$107K | – | 3519 |
|
|
2024
Q3 | $107K | Hold |
8,601
| – | – | ﹤0.01% | 3269 |
|
|
2024
Q2 | $126K | Buy |
8,601
+207
| +2% | +$3.03K | ﹤0.01% | 3120 |
|
|
2024
Q1 | $188K | Buy |
8,394
+273
| +3% | +$6.11K | ﹤0.01% | 2985 |
|
|
2023
Q4 | $153K | Sell |
8,121
-247
| -3% | -$4.65K | ﹤0.01% | 3061 |
|
|
2023
Q3 | $143K | Buy |
8,368
+240
| +3% | +$4.1K | ﹤0.01% | 3000 |
|
|
2023
Q2 | $243K | Sell |
8,128
-240
| -3% | -$7.18K | ﹤0.01% | 2704 |
|
|
2023
Q1 | $244K | Buy |
8,368
+589
| +8% | +$17.2K | ﹤0.01% | 2587 |
|
|
2022
Q4 | $154K | Buy |
7,779
+954
| +14% | +$18.9K | ﹤0.01% | 2813 |
|
|
2022
Q3 | $206K | Hold |
6,825
| – | – | ﹤0.01% | 2571 |
|
|
2022
Q2 | $157K | Sell |
6,825
-1,880
| -22% | -$43.2K | ﹤0.01% | 2663 |
|
|
2022
Q1 | $389K | Buy |
8,705
+1,880
| +28% | +$84K | ﹤0.01% | 2325 |
|
|
2021
Q4 | $263K | Hold |
6,825
| – | – | ﹤0.01% | 2539 |
|
|
2021
Q3 | $347K | Buy |
6,825
+27
| +0.4% | +$1.37K | ﹤0.01% | 2309 |
|
|
2021
Q2 | $591K | Hold |
6,798
| – | – | ﹤0.01% | 1952 |
|
|
2021
Q1 | $303K | Hold |
6,798
| – | – | ﹤0.01% | 2285 |
|
|
2020
Q4 | $174K | Buy |
+6,798
| New | +$174K | ﹤0.01% | 2200 |
|